Update 4 (10/18)
Update 3 (10/15)
Interpretation of vaccine records: CDC has not recommended the use of heterologous (i.e., mix-and-match) primary series. However, the use of such strategies (including mixing of mRNA, adenoviral, and mRNA plus adenoviral products) is increasingly common in many countries outside of the United States. Therefore, for the purposes of interpretation of vaccination records, individuals can be considered fully vaccinated ≥2 weeks after receipt of the last dose if they have received any single dose of an FDA approved/authorized or WHO EUL approved single-dose series (i.e., Janssen), or any combination of two doses of an FDA approved/authorized or WHO emergency use listed COVID-19 two-dose series.
Update 2 (10/15)
Update 1 9/20
People who were vaccinated outside the United States with a currently FDA-approved or FDA-authorized COVID-19 vaccine or a World Health Organization (WHO)-emergency use listed COVID-19 vaccine2 and who have received all the recommended doses do not need any additional doses.
Only people who have received all recommended doses of an FDA-approved, FDA-authorized, or WHO-listed COVID-19 vaccine are considered fully vaccinated for the purpose of public health guidance.
- Pfizer-BioNTech COVID-19 vaccines (e.g., COMIRNATY, Tozinameran)
- AstraZeneca-Oxford COVID-19 vaccines (e.g., Covishield, Vaxzevria)
- Janssen (Johnson & Johnson) COVID-19 vaccine
- Moderna COVID-19 vaccine
- Sinopharm BIBP COVID-19 vaccine
- Sinovac-CoronaVac COVID-19 vaccine
The CDC on Monday pointed to its prior guidance when asked what vaccines it will accept. “The CDC considers someone fully vaccinated with any FDA-authorized or approved vaccines and any vaccines that (the World Health Organization) has authorized,” said spokesperson Kristen Nordlund.
The CDC says the U.S. will accept full vaccination of travelers with any COVID-19 vaccine approved for emergency use by the World Health Organization, including those from Pfizer, Moderna and Johnson & Johnson used in the U.S. Other vaccines are also approved by the WHO and used widely around the world, including from AstraZeneca and China’s Sinovac, with varying degrees of effectiveness against COVID-19 and its more transmissible delta variant. The WHO is reviewing Russia’s Sputnik V vaccine but hasn’t approved it.
- 哪些疫苗符合规定”up to the CDC”
- “ The new policy replaces a patchwork of travel restrictions … that restricted travel by non-citizens to the United Kingdom, European Union, China, India and other countries.”